[1710.06026] Targeting Interventions in Networks

AI Drug Adherence | Gambling | Immunotherapy | Drug-Stents
Targeting interventions to high-risk populations: Benefits and costs - ScienceDirect
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiYnN3lxufxAhXJWc0KHYJxA-gQFnoECAMQAA&url=https%3A%2F%2Ffiles.eric.ed.gov%2Ffulltext%2FEJ795888.pdf&usg=AOvVaw1OeWIobVMWU77yZlElo5Al
Targeted Interventions | Child Mind Institute
Targeting Interventions in Networks | The Econometric Society
google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiYnN3lxufxAhXJWc0KHYJxA-gQFnoECBsQAA&url=https%3A%2F%2Fpapers.ssrn.com%2Fsol3%2Fpapers.cfm%3Fabstract_id%3D3054353&usg=AOvVaw28JIMtjHfSzFdFm2RavHFL
Targeting Interventions in Networks
Targeting Interventions for the Highest-Need, Highest-Cost Medicare-Medicaid Enrollees: Health Plan Approaches - Center for Health Care Strategies
Targeting interventions in networks
[PDF] Targeting Interventions for Ethnic Minority and Low-Income Populations | Semantic Scholar
Targeting (international health) - Wikipedia
Targeted Health Behavior Interventions Promoting Physical Ac... : Exercise and Sport Sciences Reviews
The effectiveness and complexity of interventions targeting sedentary behaviour across the lifespan: a systematic review and meta-analysis | International Journal of Behavioral Nutrition and Physical Activity | Full Text
Interventions targeting conscious determinants of human behaviour to reduce the demand for meat: a systematic review with qualitative comparative analysis | International Journal of Behavioral Nutrition and Physical Activity | Full Text
ISPOR - Volume 21, Supplemental S1
Login Required
Login Required
Login Required
Login Required
Login Required
Login Required
Login Required
Login Required
Login Required
Login Required
Shift in the Status Quo- How Biosimilar Interchangeability - Google Search
Shift in the Status Quo: How Biosimilar Interchangeability Can Lead to Significant Cost Savings - Value in Health
Shift in the Status Quo: How Biosimilar Interchangeability Can Lead to Significant Cost Savings | Request PDF
Biosimilar Cost Savings in the United States | RAND
Biosimilars: Still Not Quite Ready for Prime Time